Filter
391
Text search:
mutation
Featured
57
85
Language
Document type
163
82
69
24
18
13
11
4
3
2
1
Countries / Regions
23
11
10
9
9
9
8
7
6
6
6
5
5
5
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
123
42
25
11
8
6
3
1
Toolboxes
69
51
23
22
18
15
15
14
10
10
9
7
6
6
6
4
2
2
1
1
1
5th edition.
3rd edition!Large File 17 MB!
3rd edition!
guidance for health managers, health workers, and activists
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Accessed 10 April 2015
Morbidity and Mortality Weekly Report (MMWR) Early Release Vol. 64 ; 1 May 2015
